About Dr. Gordon A. Brown
Dr. Gordon A. Brown is a urologist serving adult patients throughout South Jersey. He currently practices with New Jersey Urology at offices in Cherry Hill, Sewell, and Voorhees. His practice specifically identifies Urology and Prostate Cancer among his specialties and currently lists him as accepting new patients.
His background includes advanced fellowship training in urologic oncology at the University of Texas MD Anderson Cancer Center. This additional training focuses on cancers involving the prostate, bladder, kidneys, and other parts of the urinary and male reproductive systems.
Dr. Brown also has experience with minimally invasive and robot-assisted approaches for selected urologic cancers and has contributed to professional education and research involving prostate cancer. His clinical interests extend beyond cancer to enlarged prostate and reconstructive urinary conditions.
Patients looking for related specialists can browse the Doctiplus Urology directory.
Focus Areas
- Prostate cancer
- Bladder cancer
- Kidney tumors
- Urologic oncology
- Benign prostatic hyperplasia
- Enlarged prostate symptoms
- Difficulty urinating
- Bladder disorders
- Urethral and genital reconstruction
- Cystoscopy
- Prostate biopsy
- Urinary tract evaluation
- Minimally invasive urologic surgery
- Robot-assisted urologic procedures
Prostate cancer treatment varies considerably according to tumor characteristics, stage, age, and overall health. The National Cancer Institute provides patient information about prostate cancer, including diagnosis and established treatment options.
For men experiencing urinary problems related to prostate enlargement, the NIDDK explains benign prostatic hyperplasia, including symptoms, testing, medications, and procedural treatments.
Urology and Urologic Oncology Care Approach
Urological symptoms such as difficulty urinating, blood in the urine, recurrent urinary problems, or an abnormal prostate test can have several possible causes. Evaluation may include urine testing, blood tests, imaging, cystoscopy, ultrasound, or biopsy depending on the concern.
Dr. Brown’s fellowship training is particularly relevant when cancer is suspected or already diagnosed. Urologic oncology considers both controlling the cancer and preserving urinary and sexual function when medically possible.
Treatment for prostate or other urologic cancers may involve monitoring, surgery, radiation therapy, systemic treatment, or combinations of approaches. Decisions depend on pathology findings, cancer stage, imaging results, other medical conditions, and patient preferences.
Current professional information also identifies him with reconstructive and enlarged-prostate care, including bladder reconstruction and treatment of urinary obstruction.
Education and Credentials
Dr. Brown earned his DO from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine in 1998, now known as Rowan-Virtua School of Osteopathic Medicine.
He completed postgraduate surgical and urologic training through UMDNJ/Jefferson-affiliated programs and then completed a Urologic Oncology fellowship at the University of Texas MD Anderson Cancer Center in 2007.
He holds board certification in Urological Surgery through the American Osteopathic Board of Surgery. Virtua records certification dating from 2008.
His active National Provider Identifier is 1124192489, with Urology recorded as his primary specialty and New Jersey license 25MB06991400 attached to the record.
Practice Information
Dr. Brown currently sees patients with New Jersey Urology at several South Jersey locations, including:
Cherry Hill: 2090 Springdale Road, Suite D
Sewell: 570 Egg Harbor Road, Suite A-1
Voorhees: 136 Route 73, Suites A & B
Current hospital records also associate him with Jefferson Health and Virtua facilities in New Jersey.
Patients should confirm current appointment availability, insurance participation, referral requirements, and the appropriate location directly with New Jersey Urology before scheduling.
Reviews
There are no reviews yet.